(Q46592039)

23 December 2017

title

Assessment of adherence measures with different stimulants among children and adolescents (English)

1 reference

23 December 2017

1 reference

5

James P Wilson

1 reference

23 December 2017

M. Lynn Crismon

2

object named as

M Lynn Crismon

1 reference

23 December 2017

author name string

Robert J Sanchez

1

1 reference

23 December 2017

Jamie C Barner

3

1 reference

23 December 2017

Tawny Bettinger

4

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

23 December 2017

published in

Pharmacotherapy

1 reference

23 December 2017

volume

25

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

909-917

1 reference

23 December 2017

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Introduction--ADHD comorbidity and treatment outcomes in the MTA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Adherence to treatment and health outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Enhancing drug compliance in lipid-lowering treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

A review of the literature on the economics of noncompliance. Room for methodological improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Patient adherence to treatment: three decades of research. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Relation of peripheral flow-mediated vasodilatation and coronary arterial calcium in young patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Prescription of psychotropic medications to youths in office-based practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Patient adherence to HIV medication regimens: a review of published and abstract reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Predictors of medication-refill adherence in an indigent rural population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Trends in the prescribing of psychotropic medications to preschoolers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Childhood hyperactivity and psychostimulants: a review of extended treatment studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Hyperactivity and inattentiveness. School assessment of stimulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

A psychoeducational program for children with ADHD or depression and their families: results from the CMAP feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.909

10.1592/PHCO.2005.25.7.909

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017